Aspen Aerogels (ASPN) Expected to Announce Quarterly Earnings on Thursday

Aspen Aerogels (NYSE:ASPN) is anticipated to announce its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $72.07 million for the quarter. Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. Investors may review the information on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:30 AM ET.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings results on Thursday, August 6th. The construction company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. The firm had revenue of $49.85 million for the quarter, compared to analysts’ expectations of $42.42 million. Aspen Aerogels had a negative return on equity of 31.12% and a negative net margin of 62.45%. On average, analysts expect Aspen Aerogels to post ($0.69) EPS for the current fiscal year and ($0.21) EPS for the next fiscal year.

Aspen Aerogels Stock Performance

Shares of ASPN opened at $5.01 on Tuesday. Aspen Aerogels has a 12-month low of $2.30 and a 12-month high of $8.10. The company has a current ratio of 2.52, a quick ratio of 2.24 and a debt-to-equity ratio of 0.36. The company has a market cap of $415.78 million, a PE ratio of -3.29 and a beta of 3.06. The stock has a 50-day moving average price of $5.24 and a 200-day moving average price of $4.67.

Wall Street Analysts Forecast Growth

ASPN has been the subject of several research analyst reports. Wall Street Zen upgraded shares of Aspen Aerogels from a “sell” rating to a “hold” rating in a research report on Saturday. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, September 21st. Roth Capital restated a “buy” rating and set a $7.75 price objective on shares of Aspen Aerogels in a research report on Friday, August 7th. B. Riley Financial reaffirmed a “buy” rating on shares of Aspen Aerogels in a report on Friday, August 7th. Finally, Barclays upped their target price on shares of Aspen Aerogels from $4.00 to $5.00 and gave the stock an “underweight” rating in a research report on Tuesday, August 11th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $5.94.

Insiders Place Their Bets

In other Aspen Aerogels news, major shareholder Wood River Capital, Llc sold 12,280,426 shares of the company’s stock in a transaction that occurred on Wednesday, September 23rd. The stock was sold at an average price of $4.73, for a total value of $58,086,414.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.96% of the stock is owned by insiders.

About Aspen Aerogels

Aspen Aerogels, Inc is an advanced materials company that develops, manufactures and sells aerogel-based products. Aerogels are highly porous materials used for thermal management, insulation and protection. The company serves customers in the energy, industrial, transportation and building materials markets.

Its product portfolio includes thermal barriers designed to help protect electric vehicle batteries from thermal runaway, as well as insulation products for industrial, energy infrastructure and building applications.